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Volume 56, Number 6 Abstracts 1823guidance. At the end of the procedure, minimal flow was demonstrated
and the foot was wrapped with a pressure dressing.
Results:The patient was seen back on postoperative day 5 with a repeat
duplex. The right foot duplex revealed no evidence of residual flow within
the pseudoaneurysm. The patient reports he is ambulating without diffi-
culty, and the swelling, numbness, and pain have resolved. He was released
to perform normal activity.
Conclusions: Traditional treatment of acquired arteriovenous fistula
requires open operative repair. More commonly, an endovascular approach
can be safe and effective in the treatment of acquired arteriovenous fistulas
and pseudoaneurysms involving the foot.
Fetal Demise due to Uterine Trauma With Massive Intraperitoneal
Hemorrhage Associated With Chronic Perforation of the Inferior Vena
Cava by an Infrarenal Filter: A Case Report With Call for Definitive
Consensus Regarding Filter Positioning in Nonpregnant Women of
Childbearing Age
John G. Maijub, Charles B. Ross, Molly V. Houser, Marvin E. Morris.
Norton Hospital, Louisville, Ky
Introduction: Suprarenal placement of inferior vena cava (IVC) filters
in women of childbearing age has been recommended largely based upon
theoretic concerns for safety of the mother and fetus. However, cases of
filter-related maternal and fetal injuries have not been previously reported.
Instructions for use of commercially available permanent and retrievable
IVC filters do notmake distinctions based on age or sex. Althoughmost IVC
filters implanted in current practice are potentially retrievable, less than 50%
are ever removed. We present the first report of serious maternal injury and
fetal death resulting from uterine trauma related to chronic perforation of
the IVC by an infrarenal filter, initially placed in a nonpregnant woman of
childbearing age.
Methods:A 36-year-old nonpregnant womanwas treated with chronic
anticoagulation therapy (AT) because of recurrent episodes of pulmonary
embolism (PE). She developed a retroperitoneal hemorrhage due to warfa-
rin toxicity, at which point, an infrarenal Trapease IVC filter was placed.
Indefinite AT with low-molecular-weight heparin was later initiated.
Chronic perforation of the IVC by the filter was incidentally noted 2 years
later. Filter removal by percutaneous means was contraindicated, and given
her asymptomatic status, operative removal was not offered. One year later,
at age 39, she became pregnant. At an estimated intrauterine pregnancy age
of 24 weeks, after physical activity, the patient developed sudden, extreme
abdominal and back pain with associated dyspnea. A pulmonary computed
tomography angiogram demonstrated no PE but showed free intraperito-
neal fluid. She became hemodynamically unstable, concurrent with dramatic
fall in fetal heart rate.
Results: Laparotomy and caesarean section were immediately per-
formed, but the fetus was not salvageable. Bleeding was noted from a
laceration to the dome of the uterus and was closed with chromic suture. A
tear was noted in the peritoneal membrane overlying the filter, with barbs
and vertical struts of the filter freely exposed. The vertical struts and barbs of
the filter were removed, but due to instability, complete removal of the filter
and IVC reconstruction was not deemed safe. Instead, the filter-bearing IVC
was wrapped with a vascularized, transmesocolic omental flap. The patient’s
hospital course, 13 days, was complicated by intraperitoneal abscess (drained
percutaneously) and wound infection. Complete healing was achieved at 10
weeks postoperatively. The patient is doing well at 4 months. Chronic AT
Fig 2.with low-molecular-weight heparin has been continued, and the patient
advised to avoid future pregnancies.
e
dConclusions: Interaction between the gravid uterus and an infrarenally
ositioned IVC filter, presumed in the past to be a theoretic risk for IVC
ompression and thrombosis or perforation, is proven by this case to be a real
isk. Although the filter in this case was a permanent type, use of an optional
lter does not obviate this risk, because a large majority of optional filters are
ever removed. Societal consensus and device manufacturers should address
his potential risk in guidelines for filter placement, positioning (preferably
uprarenal), and emphasis on subsequent, planned filter retrieval when IVC
lters are placed in nonpregnant women of childbearing age.
inimally Invasive Management of Symptomatic Pulmonary Seques-
ration With an Aneurysmal Feeding Vessel: Coil Embolization Com-
ined With Thorascopic Resection
yla Shelton, Matthew Steliga, John Eidt. University of Arkansas for
edical Sciences, Little Rock, Ark
Introduction: Pulmonary sequestration is an uncommon develop-
ental anomaly characterized by nonfunctioning lung tissue that does not
sually communicate with the native bronchial tree and its blood supply is
erived from a variety of systemic arterial sources. We present a case of a
ymptomatic pulmonary sequestration, complicated by an aneurysmal feed-
ng vessel, treated with a combined minimally invasive endovascular and
horascopic approach.
Methods: The patient is a 35-year-old woman with a pulmonary
equestration of the right lower lobe. She had a history of recurrent pulmo-
ary infections. A computed tomography scan to evaluate abdominal pain
evealed a pulmonary sequestration of the medial aspect of the right lower
obe. The feeding vessel originated from the left gastric artery and was
neurysmal (1.8 cm) at the level of the diaphragm. A combined endovascular
nd thorascopic procedure was chosen. Through a common femoral artery
ccess, the left gastric artery and feeding vessel was catheterized. Coil
mbolization was performed distal to the aneurysm and into the aneurysmal
ac using detachable coils. Completion angiogram showed no flow in the
neurysm or feeding vessel. Thoracic surgery then proceeded with resection
f the sequestration via video-assisted video-assisted thoracoscopy. A thick-
ned pale area of lung that did not deflate with single-lung ventilation was
dentified (Video). The sequestration was resected completely.
Results: The patient’s postoperative course was uneventful, and she
as remained asymptomatic at 24 months.
Conclusions: Pulmonary sequestration is an uncommon developmen-
al anomaly that may present with recurrent pulmonary infections. Resection
s curative. We have speculated that the aneurysm was related to shearing of
he feeding vessel as it penetrated the diaphragm. Combined endovascular
nd thorascopic treatment represents a minimally-invasive alternative to
onventional open thoracotomy.
nterleukin-1 Pathway Antagonism Prevents and Treats Experimen-
al Aortic Aneurysms
illiam F. Johnston, Morgan Salmon, Gang Su, Yunge Zhou, Gary K.
wens, Gilbert R. Upchurch, Jr, Gorav Ailawadi. University of Virginia,
harlottesville, Va
Introduction: Interleukin-1 (IL-1) is a proinflammatory cytokine
levated in both human and experimental abdominal aortic aneurysms
AAAs). IL-1 signals the inflammatory cascade through binding the inter-
eukin-1 receptor (IL-1R). The study objective was to evaluate pharmaco-
ogic opposition of IL-1 signaling using the recombinant IL-1R antagonist
nakinra for prevention and treatment of experimental AAAs.
Methods: To evaluate AAA prevention with anakinra, four groups of
- to 10-week-old male C57Bl/6 mice (n 7/group) underwent subcuta-
eous placement of continuous-release osmotic pumps filled with escalating
oses of anakinra. All mice underwent aortic elastase perfusion 3 days after
nakinra pump placement. Maximal aortic dilation was measured 14 days
fter elastase perfusion. Aortic samples were evaluated with immunohisto-
hemistry for macrophages, neutrophils, and elastin. IL-1 protein levels
ere measured by enzyme-linked immunosorbent assay. To determine if
reatment with anakinra could inhibit aneurysm progression once an AAA
as initiated or a small AAA existed, 8-to- 10-week-old male C57Bl/6 mice
nderwent elastase perfusion, followed by osmotic pump placement 3 days
r 7 days afterward (7 per group for day 3 and 5 per group for day 7). Pumps
ere filled with anakinra or vehicle as a control. Aortic dilation was measured
t harvest, and tissue was analyzed with immunohistochemistry for macro-
hages, neutrophils, elastin, and IL-1.
Results: Increasing doses of anakinra resulted in a stepwise attenuation
n aortic dilation, with mean aortic dilations of 86.3%  5.7% for vehicle
nly, 74.9%  5.9% for 10 mg/kg/d anakinra, 56.8%  3.3% for 30
g/kg/d anakinra, and 48.3% 4.6% for 100 mg/kg/d anakinra (P .05
or 30 mg/kg/d and 100 mg/kg/d vs vehicle by analysis of variance).
scalating doses of anakinra pretreatment also corresponded with a dose-
ependent decrease in macrophage and neutrophil infiltration, as well as
lastin degradation compared with vehicle-treated mice at 14 days. Aortic
ilation significantly correlated with IL-1 protein levels (R  .575; 95%
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December 20121824 Abstractsconfidence interval, 0.203-0.802; P  .01). Treatment with anakinra start-
ing 3 or 7 days after elastase exposure significantly reduced aortic dilation
compared with vehicle alone. Treatment starting 3 days after elastase re-
sulted in 43.7% 8.3% dilation vs 86.4% 3.5% dilation with vehicle alone
(P  .0005). Anakinra treatment starting 7 days after elastase exposure
reduced aortic dilation from 82.4%  6.9% with vehicle alone to 52.9% 
1.4% (P  .005). Aortas treated with anakinra demonstrated less macro-
phage and neutrophil infiltration, less elastin degradation, and less IL-1.
Conclusions: IL-1 signaling was critical for AAA formation, and
inhibition of its corresponding receptor through receptor antagonism with
anakinra attenuated AAA formation, macrophage and neutrophil infiltra-
tion, and elastin degradation. Furthermore, delayed initiation of IL-1R
antagonism after early aneurysm formation inhibited AAA progression,
suggesting that IL-1 pathway antagonism may function as a novel treat-
ment strategy for AAAs.
A Novel Depletion Approach Attenuates a Surge of CD34 Progenitors
After Vascular Injury: Implications for Restenotic Vascular Disease
Bryan Tillman, Justine Kim, Adriana Harbuzariu. University of Pittsburgh
School of Medicine, Pittsburgh, Pa
Introduction: Intimal hyperplasia is an overactive healing response
that leads to failure of half of all vascular interventions in 5 years. Increas-
ing evidence suggests that circulating progenitor cells expressing the marker
CD34 play an important role in this disease. Several studies have highlighted
either a direct cellular contribution to intimal lesions or by fostering a
favorable environment for restenosis. Despite their evolving importance in
this clinically important disease, the kinetics of CD34 cell mobilization after
vascular injury are not known. In addition, there is no way to specifically
intervene on these cells. In this study, we investigated the timecourse of
CD34-positive progenitor cells after vascular injury and examined whether
an affinity pheresis approach could mediate systemic depletion of CD34-
positive cells at the time of vascular injury in a large-animal model.
Methods: An ovine model underwent placement of an arteriovenous
polytetrafluorethylene graft between the carotid and jugular veins. The
contralateral carotid underwent balloon angioplasty. Endothelial injury in
this model was confirmed by scanning electron microscopy. The first groups
of animals underwent flow cytometric assessment of CD34/vascular endo-
thelial factor receptor 2-positive cells after vascular (n  3) and a control,
nonvascular surgery (n  3). Next, separate groups underwent vascular
injury, and over 14 days, the model underwent serial depletion using affinity
pheresis toward the progenitor cell marker CD34 (n 3) or a mock control
(n  4). Cells bound to the affinity system were eluted enzymatically and
examined by flow cytometry. Finally, complete blood counts were compared
between the study groups for changes after affinity pheresis.
Results: Our findings suggest a surge of CD34-positive cells after
vascular intervention that is not observed after control surgical procedures
(Fig 1). Our pheresis group revealed that the surge can be attenuated by a
CD34 affinity pheresis but not by a mock control (Fig 2). Consistent with
these findings, cells recovered from the affinity cartridge revealed large
numbers of CD34-positive cells that were not found in the control group.
Finally, our findings revealed that even after multiple sessions with an affinity
pheresis device, complete blood counts remain essentially unchanged.Fig.Conclusions: This study is the first to document a surge of CD34-
ositive progenitors that appears to be limited to macrovascular injury. This
nding may have important implications on the pathology of vascular
estenosis. We further conclude that CD34 affinity pheresis can mediate
ignificant in vivo depletion of circulating progenitor cells. Our results also
ndicate that the specificity of this depletion has minimal impact on clinical
easures of blood composition. Given the evolving role of these cells in the
athology of restenosis, this approach may have important clinical implica-
ions. Future studies will evaluate the implications of this depletion on
ecurrent vascular disease.
-2a Agonist Dexmedetomidine Interrupts Macrophage Toll-Like
eceptor 4 Signaling in Murine Model of Spinal Cord
schemia–Reperfusion
arshall T. Bell, Viktor A. Agoston, Ferenc Puskas, Joseph C. Cleveland, Jr,
avid A. Fullerton, Kristen Freeman, Fabia Gamboni, Paco Herson, Joshua
ares, Michael J. Weyant, T. Brett Reece. University of Colorado, Aurora,
olo
Introduction: Paraplegia persists after thoracoabdominal aortic inter-
entions despite investigation into preventative pharmacologic adjuncts.
he 
-2a adrenergic receptor agonist, dexmedetomidine, has been shown to
reserve neurologic function and neuronal viability in a murine model of
pinal cord ischemia–reperfusion, although the mechanism remains elusive.
e hypothesize that dexmedetomidine will blunt the inflammation of
eperfusion effects in vivo after thoracic aortic occlusion with in vitro
emonstration of microglial inhibition via blunted Toll-like receptor (TLR)
signaling
Methods: Adult male C57BL/6 mice underwent 4 minutes of aortic
cclusion. Treatment groups received 25 g/kg dexmedetomidine at rep-
rfusion and at 12-hour intervals postprocedurally. Functional scoring was
one at 6 hours after surgery and at 12-hour intervals until 60 hours, when
pinal cords were removed and examined for neuronal viability and cytokine
roduction. Spinal cords from identical mice were removed for microglial
solation culture. Cells were grown to confluence and stimulated with the
LR-4 agonist LPS 10 ng/mL in presence of dexmedetomidine or vehicle
ontrol. Media was then removed for cytokine analysis. All treatment groups
ere compared with ischemic controls and significance determined by P 
05.
Results: Dexmedetomidine treatment significantly preserved neuro-
ogic function, cytoarchitecture, and neuronal viability in the murine spinal
ord. Treatment was associated with significantly reduced IL-6 production
t 6 and 60 hours. Microglial cells stimulated with LPS had production of
roinflammatory cytokines tumor necrosis factor-
 and interleukin-6, which
as significantly attenuated with treatment of dexmedetomidine.
Conclusions: The 
-2a agonist, dexmedetomidine, preserved neu-
ologic function and attenuated proinflammatory cytokine production in
n vivo and in vitro murine models. Furthermore, this relationship
ppears to occur through interruption of TLR-4–mediated microglial
ctivation and cytokine production. This involvement of TLR-4 signal-
ng in dexmedetomidine protection provides an insight into the mecha-
ism of paralysis after thoracic aortic interventions to guide future
harmacologic targets for attenuating spinal cord ischemia and reperfu-
ion injury.
Fig 1.
